Company

Recipharm

2022

Quick facts

1,828,439

Emissions (ton CO₂e)

1,293

Revenue (M USD)

1,414

Intensity (t CO₂e / M USD)

Ambition & Development

In 2022, Recipharm reported a total of 1,828,439 ton CO₂e, and a net revenue of 1,293 M USD, resulting in a emissions intensity of 1,414 t CO₂e / M USD.

Targets

Base year:

2021

Target year:

2030

Reduction:

0.42

Classification:

1.5°C

Recipharm commits to reduce absolute scope 1 and 2 GHG emissions 42.1% by 2030 from a 2021 base year*. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.

Source: Science Based Target initative

Emissions, Revenue & Intensity

Emissions, Target & Trend

Report missing data

Revenue	2021	2022
Net Revenue (M USD)	1,210	1,293
Revenue Source

Emissions Overview	2021	2022
Total Emissions - Market Based (t CO₂e)	1,697,115	1,828,439
Emissions Intensity (t CO₂e / M USD)	1,403	1,414
Cradle-to-gate Intensity (t CO₂e / M USD)	75	59

Emissions Details	2021	2022
Scope 1 Emissions (t CO₂e)	80,282	61,189
Scope 2 Emissions (t CO₂e)
Scope 2 - Market Based	10,572	15,293
Scope 2 - Location Based
Scope 2 - Not specified
Scope 3 Emissions (t CO₂e)	1,606,261	1,751,957
Upstream Emissions (t CO₂e)
1. Purchased goods and services
2. Capital goods
3. Fuel- and energy-related activities
4. Upstream transportation and distribution
5. Waste generated in operations
6. Business travel
7. Employee commuting
8. Upstream leased assets
Downstream Emissions (t CO₂e)
9. Downstream transportation and distribution
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions (t CO₂e)	1,697,115	1,828,439
Emission Source

Open Sustainability Index

Licensed under CC BY-SA 4.0